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Abstract: The preparation, characterization and electrochemical and photophysical properties of a 
series of desymmetrized heteroleptic [Cu(P^P)(N^N)][PF6] compounds are reported. The complexes 
incorporate the chelating P^P ligands bis(2-(diphenylphosphanyl)phenyl)ether (POP) and (9,9-di-
methyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane) (xantphos), and 6-substituted 2,2′-bipyridine 
(bpy) derivatives with functional groups attached by –(CH2)n– spacers: 6-(2,2′-bipyridin-6-yl)hexa-
noic acid (1), 6-(5-phenylpentyl)-2,2′-bipyridine (2) and 6-[2-(4-phenyl-1H-1,2,3,triazol-1-yl)ethyl]-
2,2′-bipyridine (3). [Cu(POP)(1)][PF6], [Cu(xantphos)(1)][PF6], [Cu(POP)(2)][PF6], 
[Cu(xantphos)(2)][PF6], and [Cu(xantphos)(3)][PF6] have been characterized in solution using mul-
tinuclear NMR spectroscopy, and the single crystal structure of [Cu(xantphos)(3)][PF6].0.5Et2O was 
determined. The conformation of the 6-[2-(4-phenyl-1H-1,2,3,triazol-1-yl)ethyl]-substituent in the 
[Cu(xantphos)(3)]+ cation is such that the α- and β-CH2 units reside in the xanthene ‘bowl’ of the 
xantphos ligand. The 6-substituent desymmetrizes the structure of the [Cu(P^P)(N^N)]+ cation and 
this has consequences for the interpretation of the solution NMR spectra of the five complexes. The 
NOESY spectra and EXSY cross-peaks provide insight into the dynamic processes operating in the 
different compounds. For powdered samples, emission maxima are in the range 542–555 nm and 
photoluminescence quantum yields (PLQYs) lie in the range 13–28%, and a comparison of PLQYs 
and decay lifetimes with those of [Cu(xantphos)(6-Mebpy)][PF6] indicate that the introduction of 
the 6-substituent is not detrimental in terms of the photophysical properties. 
Keywords: copper(I); bisphosphane; 2,2′-bipyridine; photophysics; X-ray diffraction 
 
1. Introduction 
Copper(I) coordination compounds are a focus of attention as efficient emissive ma-
terials for organic light emitting diodes (OLEDs) [1] and light-emitting electrochemical 
cells (LECs) [2–6]. In a LEC, an ionic transition metal complex (iTMC) can function both 
as the emitter and as charge carrier. Heteroleptic [Cu(P^P)(N^N)]+ complexes in which 
N^N is a diimine and P^P is a bisphosphane are of particular interest because many ex-
hibit thermally activated delayed fluorescence (TADF) [7–9]. In TADF-compounds, the 
energy gap between the excited singlet and triplet states is small, leading to reverse inter-
system crossing which gives rise to enhanced photoluminescence quantum yields 
(PLQYs). The current generations of [Cu(P^P)(N^N)]+ complexes have their origins in de-
rivatives containing 2,2′-bipyridine (bpy) or 1,10-phenanthroline (phen) which were 
found by McMillin to exhibit low-lying metal-to-ligand charge transfer (MLCT) excited 
states [10,11]. 
Improving the photophysical properties of [Cu(P^P)(N^N)]+ complexes can be ap-
proached by structural modification of either the P^P or N^N domains. Typically, the P^P 
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ligand is a wide bite-angle bisphosphane such as bis(2-(diphenylphosphanyl)phe-
nyl)ether (POP) or (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane) 
(xantphos) (Scheme 1) and these commercially available ligands remain the most popular 
choices. While structure–property relationships may be developed [12–14], enhanced 
PLQY is most often the result of trial-and-error structural variation of the N^N ligand. 
Synthetically, it is easier to vary the functionalities in the latter than in the P^P domain. It 
has also been shown that intramolecular π-stacking interactions in [Cu(P^P)(phen)]+ and 
[Cu(P^P)(4,7-Ph2phen)]+ (4,7-Ph2phen = 4,7-diphenyl-1,10-phenanthroline) lead to in-
creased PLQY values because of inhibition of the flattening of the coordination sphere in 
the excited state [15]. In addition to enhancing photophysical behaviour, one of the chal-
lenges in the design of [Cu(P^P)(N^N)]+ emitters is to minimize the tendency for ligand-
redistribution reactions. One approach has been to use macrocyclic ligands to produce 
pseudorotaxanes [16]. The covalent linkage of the P^P and N^N domains is an attractive 
way forward but appears to have been little explored. This approach will involve the use 
of longer chains as linkers, and strategies that might be developed involve condensation 
reactions between appropriate functionalities on the P^P and N^N domains, or the use of 
click chemistry. In this paper, we consider the consequences on the structural, dynamic 
and photophysical properties of copper(I) iTMCs of the desymmetrization caused by the 
introduction of model linker chains at the 6-position of a bpy (ligands 1–3 in Scheme 1). 
We have previously demonstrated that the introduction of 6-methyl, 6-ethyl, 6-phenyl or 
6-phenylthio substituents is beneficial to the photophysical properties of [Cu(POP)(bpy)]+ 
and [Cu(xantphos)(bpy)]+ derivatives [17–19]. However, to the best of our knowledge, lit-
tle is known about the effects of introducing longer, and potentially sterically demanding, 
6-substituents. 
 
Scheme 1. Structures of the P^P and N^N ligands with labelling for the NMR assignments. 
2. Results and Discussion 
2.1. Ligand Syntheses  
Compound 1 has previously been reported and was prepared according to the pub-
lished method [20]. The route shown in Scheme 2 was used to synthesize compound 2. 
The first step was lithiation of the methyl group in 6-methyl-2,2′-bipyridine (6-Mebpy) 
using lithium diisopropylamide (LDA) prepared in situ. The intermediate was then 
treated with 1-bromo-4-phenylbutane to give 2. The base peak at m/z 303.10 in the elec-
trospray (ESI) mass spectrum arose from the [M + H]+ ion. The 1H- and 13C{1H}-NMR spec-
tra were assigned using 2D methods, and HMQC and HMBC spectra are shown in Figures 
S1 and S2 in the Supporting Material. 




Scheme 2. Synthetic route to compound 2. Reagents and Conditions: (i) Lithium diisopropylamide 
(LDA), THF, −78 °C; (ii) 1-bromo-4-phenylbutane, THF, room temperature. Yield = 30%. 
Compound 3 was prepared by adapting a literature procedure [21] and the synthetic 
route is summarized in Scheme 3. The base peak (m/z 328.08) in the ESI mass spectrum 
corresponded to the [M + H]+ ion, and the 1H and 13C{1H} NMR spectra (assigned using 
COSY, NOESY and HMQC and HMBC methods) were fully in accord with the structure 
shown in Scheme 3. Figure 1 illustrates the 1H NMR spectrum of 3, and additional spectra 
are presented in Figures S3 and S4. Using the atom numbering given in Scheme 1, protons 
Ha and Hb were distinguished by the observation of NOESY crosspeaks between Ha and 
HB5, and between Hb and HE5 (Figure 1b).  
 
Scheme 3. Synthetic route to compound 3. Reagents and Conditions: (i) NaN3, DMF, room temper-
ature; (ii) phenylethyne, CuSO4.5H2O, sodium ascorbate, t-BuOH/H2O, 35 °C. Yield = 54%. 
 
Figure 1. (a) The 1H-NMR spectrum (500 MHz, CDCl3, 298 K) of compound 3, and (b) part of the 
NOESY spectrum of 3 (500 MHz, CDCl3, 298 K). * = residual CHCl3. 
2.2. Synthesis and Characterization of Heteroleptic Copper(I) Complexes 
[Cu(POP)(1)][PF6] and [Cu(POP)(2)][PF6] were prepared by initially reacting 
[Cu(MeCN)4][PF6] and POP in CH2Cl2, followed by the addition of 1 or 2. For the 
xantphos-containing compounds, xantphos and the N^N ligand were added at the same 
time to a CH2Cl2 solution of [Cu(MeCN)4][PF6]. The reasons for these different routes have 
previously been discussed [18]. [Cu(POP)(1)][PF6], [Cu(POP)(2)][PF6], 
[Cu(xantphos)(1)][PF6], [Cu(xantphos)(2)][PF6] and [Cu(xantphos)(3)][PF6] were isolated 
as yellow solids in yields ranging from 78% to 99%. Positive-mode ESI mass spectra 
showed peaks arising from the [M − PF6]+ ion and in all but [Cu(xantphos)(3)][PF6], this 
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was the base peak. For [Cu(xantphos)(3)][PF6], a low intensity peak at m/z 968.26 corre-
sponded to [M − PF6]+ and the base peak at m/z 811.16 was assigned to the fragment ion 
[Cu(xantphos)(Mebpy)]+. For each compound, the presence of the [PF6]− counterion was 
confirmed in the negative-mode ESI mass spectrum, and by a characteristic septet in the 
31P{1H} NMR spectrum. A singlet at δ –13.1 ppm in the 31P{1H} NMR spectra of 
[Cu(P^P)(1)][PF6] and [Cu(P^P)(2)][PF6] was assigned to the POP or xantphos ligand, 
while in [Cu(xantphos)(3)][PF6], the xantphos ligand gave rise to a signal at δ –12.7 ppm. 
Before considering the NMR characterization of the complexes, we present the crystal 
structure of [Cu(xantphos)(3)][PF6].0.5Et2O. 
Single crystals of [Cu(xantphos)(3)][PF6].0.5Et2O were grown from a CH2Cl2 of the 
compound layered with diethyl ether. The compound crystallizes in the triclinic space 
group P–1. Disorder of the phenyl ring of the coordinated ligand 3 (see the experimental 
section) meant that this part of the structure was refined isotropically, as seen in the OR-
TEP representation in Figure S5 in the Supporting Material. Table 1 presents important 
bond lengths and angles, and P–C bond lengths are typical, lying in the range 1.827(3) to 
1.834(3) Å. Atom Cu1 in the [Cu(xantphos)(3)]+ cation is in a distorted tetrahedral envi-
ronment, with the largest angle in the coordination sphere being P2–Cu1–N2 = 118.78(7)o. 
Figure 2a,b show two views of the [Cu(xantphos)(3)]+ cation, and is noteworthy that the 
6-substituent lies over and to one side of the ‘bowl’ shaped cavity of the xanthene; this is 
relevant to the subsequent NMR spectroscopic discussion. The space-filling diagram in 
Figure 2c illustrates that the conformation of the chain is such that is desymmetrizes the 
structure. It is tempting to suggest that this is associated with a stacking of the triazole 
ring over one arene ring of the xanthene. However, the distance between the ring-cen-
troids is 4.07 Å indicating that this is, at best, a weak π-interaction. Figure 2b reveals that 
two of the PPh2 phenyl rings are aligned to give a π-stacking interaction. The angle be-
tween the ring planes is 10.0°, and the centroid...centroid distance is 3.85 Å, making this 
an effective interaction and one that is typical in many [Cu(xantphos)(N^N)]+ complexes 
[19]. Figure S6 illustrates this interaction and also highlights the proximity of bpy proton 
HA6 (see Scheme 1) to the stacked rings which is pertinent to the NMR spectroscopic dis-
cussion below. 
 
Figure 2. (a,b) Two views of the [Cu(xantphos)(3)]+ cation, and (c) a space-filling representation of 
diagram (b). 
Table 1. Selected bond lengths and angles in the [Cu(xantphos)(3)]+ cation. See Figure S5 (Support-
ing Material) for atom numbering. 
Bond  Bond Length/Å Angle Bond Angle/o 
Cu1–P1 2.2673(7) P1–Cu1–P2 114.33(3) 
Cu1–P2 2.2591(7) P1–Cu1–N1 113.50(7) 
Cu1–N1 2.063(2) P2–Cu1–N1 111.67(7) 
Cu1–N2 2.066(2) P1–Cu1–N2 113.80(7) 
O1–C20 1.384(3) P2–Cu1–N2 118.78(7) 
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O1–C22  1.388(3) N1–Cu1–N2 80.18(10) 
N3–N4  1.332(5) C20–O1–C22 114.96(19) 
N4–N5  1.316(5) N3–N4–N5 108.8(3) 
Attempts to grow X-ray quality crystals of the remaining four complexes were un-
successful, and we therefore modelled one of the POP-containing complexes in order to 
gain information about the structural relationship between the substituent attached to the 
bpy domain, and the POP ligand. The structure of [Cu(POP)(1)]+ was minimized, first at 
a molecular mechanics (MM2) level, and this geometry was used as an input to a DFT 
level energy minimization (B3LYP 6-31G*) [22]. Figure 3 shows the minimized structures 
of the [Cu(POP)(1)]+, [Cu(POP)(2)]+, [Cu(xantphos)(1)]+ and [Cu(xantphos)(2)]+ cations. 
Significantly, the 6-substituent is positioned over one phenyl ring of the POP-backbone 
(Figure 3a,b) or over one arene ring of the xanthene unit (Figure 3c,d), in a similar orien-
tation to that observed for the triazole-containing chain in the solid-state structure of 
[Cu(xantphos)(3)][PF6] (Figure 2). 
 
Figure 3. The energy minimized structures of the cations (a) [Cu(POP)(1)]+, (b) [Cu(POP)(2)]+, (c) 
[Cu(xantphos)(1)]+ and (d) [Cu(xantphos)(2)]+. 
2.3. NMR Spectroscopic Properties and Dynamic Behaviour 
The 1H- and 13C{1H}-NMR spectra of the complexes were recorded in acetone-d6 and 
assigned using a combination of COSY, NOESY, HMQC and HMBC methods. 1H-NMR, 
HMQC and HMBC spectra are depicted in Figures S7–S21 in the Supporting Material, and 
full assignments are given in the Material and Methods section. Figure 4 compares the 
aromatic regions of the 1H-NMR spectra of [Cu(POP)(1)][PF6] and [Cu(xantphos)(1)][PF6]. 
Several features are of note. First, on going from Figure 4a to 4b, the signal for HC6 is lost 
as the CMe2 unit is introduced into the P^P ligand backbone (Scheme 1). Secondly, in the 
spectrum of [Cu(xantphos)(1)][PF6], the signal for bpy HA6 is broadened, and presumably 
this is associated with the proximity of this proton to two phenyl rings of the PPh2 groups 
of the xantphos ligand (see Figure S6). The third notable distinction between the 1H spec-
tra is the splitting of the signals for the phenyl rings into two sets (labelled D and D’), a 
phenomenon more pronounced in [Cu(xantphos)(1)][PF6] than [Cu(POP)(1)][PF6]. The 
difference is also apparent in the HMQC spectra, expansions of which are displayed in 
Figure 5.  




Figure 4. Aromatic regions of the 1H-NMR spectra (500 MHz, acetone-d6, 298 K) of (a) 
[Cu(POP)(1)][PF6] and (b) [Cu(xantphos)(1)][PF6]. 
 
Figure 5. Part of the HMQC spectra (1H 500 MHz, 13C 126 MHz, acetone-d6, 298 K) of (a) 
[Cu(xantphos)(1)][PF6] and (b) [Cu(POP)(1)][PF6]. 
Non-dissociative dynamic processes to be considered include: (i) rotation of the phe-
nyl rings around P–C bonds which has a very low energy barrier; (ii) conformational 
change of the 6-substituent from the left- to the right-side of the complex as defined in 
Scheme 4a; (iii) the conformational change of the POP backbone (Scheme 4b), or confor-
mational change of the xanthene unit in xantphos (Scheme 4c). We may assume that pro-
cess (i) occurs in all the complexes at 298 K. Processes (ii) and (iii) may be coupled or 
independent, and the series of complex cations described here reveals different scenarios. 
First, we compare [Cu(xantphos)(1)][PF6] and [Cu(POP)(1)][PF6]. The NOESY spectra in 
Figures 6 and 7 are particularly informative. The backbone of the xanthene unit is less 
flexible than that of POP, and the conformational change for xanthene (Scheme 4c) is ex-
pected to be a higher energy process than that of POP (Scheme 4b). There are no exchange 
(EXSY) peaks between the signals for the xantphos HMe and HMe’ protons in 
[Cu(xantphos)(1)][PF6] (top part of Figure 6a), consistent with no conformational change 
of the xanthene unit. Additionally, no EXSY peaks are observed between the PPh2 HD2 and 
HD2′ protons. As Figure 7a shows for [Cu(xantphos)(1)][PF6], in addition to a NOESY cross-
peak to HB5(bpy), the protons in the CH2 group attached to the bpy unit (Ha in Scheme 1) 
show a NOESY crosspeak with HD2, but not with HD2′. The data are consistent with the 6-
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substituent undergoing the conformational change shown in Scheme 4a. This in not cou-
pled with inversion of the xanthene unit (i.e., the process in Scheme 4c is not fast on the 
NMR timescale at 298 K). In contrast, in the NOESY spectrum of [Cu(POP)(1)][PF6] (Figure 
6b), EXSY peaks are observed between HD2 and HD2′, indicating that phenyl rings D and 
D’ exchange, but the process in slow enough on the NMR timescale at 298 K that signals 
for phenyl groups in two chemically different environments remain distinct. Significantly, 
the signal for the CH2 group attached to bpy in [Cu(POP)(1)][PF6] is an overlapping dou-
blet of doublets (Figure 7b), indicating that these protons are diastereotopic. Figure 7b 
shows part of the NOESY spectrum of [Cu(POP)(1)][PF6], where separate crosspeaks be-
tween Ha and HD2, and between Ha’ and HD2′, in addition to the Ha/Ha’ to HB5(bpy) cross-
peaks are observed. The data for [Cu(POP)(1)][PF6] are therefore in accord with a combi-
nation of the processes shown in Schemes 4a and 4b. Analyses of the NMR spectra of 
[Cu(xantphos)(2)][PF6] and [Cu(POP)(2)][PF6] demonstrate that their dynamic behaviours 
mimic those of [Cu(xantphos)(1)][PF6] and [Cu(POP)(1)][PF6], respectively (Figures S22 
and S23 in the Supporting Material). 
 
Scheme 4. Some of the possible dynamic processes in [Cu(P^P)(N^N)]+ cations: (a) desymmetriza-
tion of the P^P ligand by conformational change of a 6-substituent when N^N = bpy, (b) conforma-
tional change of the POP backbone, and (c) inversion of the xanthene unit in xantphos which ex-
changes the positions of the methyl groups with respect to the O atom in the xanthene unit. 




Figure 6. Part of the NOESY spectra (500 MHz, acetone-d6, 298 K) of (a) [Cu(xantphos)(1)][PF6] with the methyl region 
shown at the top, and (b) [Cu(POP)(1)][PF6]. EXSY peaks appear in the opposite phase (blue) to NOESY crosspeaks (red), 
and are observed between HD2 and HD2′ in [Cu(POP)(1)][PF6] but not in [Cu(xantphos)(1)][PF6]. 
 
Figure 7. Part of the NOESY spectra (500 MHz, acetone-d6, 298 K) of (a) [Cu(xantphos)(1)][PF6] showing NOESY cross-
peaks between Ha and HB5, and Ha and HD2, and (b) [Cu(POP)(1)][PF6] showing crosspeaks between the diastereotopic 
protons Ha/Ha’ and HB5, between Ha and HD2, and between Ha’ and HD2′. 
In contrast to the dynamic behaviour in [Cu(xantphos)(1)][PF6] and 
[Cu(xantphos)(2)][PF6], [Cu(xantphos)(3)][PF6] undergoes a combination of the processes 
illustrated in Schemes 4a and 4c. The 1H- and 13C{1H}-NMR spectra of an acetone-d6 solu-
tion of [Cu(xantphos)(3)][PF6] (298 K) display two sets of signals for the PPh2 phenyl rings, 
and in the NOESY spectrum, EXSY peaks are observed between the HD2/HD2′, HD3/HD3′, 
and HD4/HD4′ pairs (Figure 8a). Critically, there are EXSY peaks between the two methyl 
groups of the CMe2 unit of xantphos (Figure 8b) confirming that the xanthene unit under-
goes a conformation change (Scheme 4c) which is slow on the NMR timescale at 298 K. 
The NMR spectroscopic data are consistent with this being combined with the ‘flip’ of the 
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6-substituent (Scheme 4a). It is possible that this is associated with the presence of the 
aromatic triazole unit in the middle of the substituent chain (see structural discussion and 
Figure 2). 
 
Figure 8. Part of the NOESY spectra (500 MHz, acetone-d6, 298 K) of [Cu(xantphos)(3)][PF6]. (a) The EXSY between HD2 
and HD2′, and between HD3 and HD3′; the EXSY peaks between HD4 and HD4′ are also visible close to the diagonal. (b) EXSY 
peaks between HMe and HMe’ in the xanthene unit. 
2.4. Electrochemical and Photophysical Properties 
The electrochemical behaviour of the copper(I) compounds was investigated using 
cyclic voltammetry and Table 2 summarizes the observed processes. For comparison, the 
parent compounds [Cu(POP)(bpy)][PF6] and [Cu(xantphos)(bpy)][PF6] undergo a reversi-
ble copper(I) oxidation at +0.72 V and +0.76 V, respectively [23], and, on going from 
[Cu(xantphos)(bpy)][PF6] to [Cu(xantphos)(6-Mebpy)][PF6] to [Cu(xantphos)(6,6′-
Me2bpy)][PF6], oxidation of Cu+ occurs at higher potentials (E1/2ox = +0.76 V, +0.85 V and 
+0.96 V, respectively) [23]. Although the copper oxidation for each of the compounds re-
ported in Table 2 is irreversible, the Epc values are similar to the E1/2ox for [Cu(xantphos)(6-
Mebpy)][PF6] to [Cu(xantphos)(6,6′-Me2bpy)][PF6], and are consistent with the steric de-
mands of the 6-substituents hindering the flattening of the copper coordination sphere 
which accompanies oxidation from Cu+ to Cu2+. Each compound also undergoes a reversi-
ble bpy-centred reduction, and Figure S24 in the Supporting Material shows cyclic volt-
ammograms (CVs) for [Cu(POP)(2)][PF6] and [Cu(xantphos)(2)][PF6] as representative 
data. 
Table 2. Copper(I)/(II) oxidation potentials in the copper(I) compounds. Propylene carbonate solu-
tions (ca. 10−4 mol dm–3); values are referenced internally to Fc/Fc+ = 0.0 V; [nBu4N][PF6] as support-
ing electrolyte and scan rate of 0.1 V s–1. 
Compound Epc a/V E1/2/V Epc − Epa/mV 
[Cu(POP)(1)][PF6] +0.85 −2.07 80 
[Cu(xantphos)(1)][PF6] +0.93 −2.06  90 
[Cu(POP)(2)][PF6] +0.92 −2.10 120 
[Cu(xantphos)(2)][PF6] +0.94 −2.13 130 
[Cu(xantphos)(3)][PF6] +0.81 −2.02  90 
a The value Epc is given rather than E1/2ox because each oxidative process is irreversible. 
The solution absorption spectra of the heteroleptic compounds are displayed in Fig-
ure 9 and absorption maxima are given in Table 3. Absorptions below ca. 330 nm arise 
from ligand-centred transitions. These regions of the spectra of the two POP-containing 
compounds are similar, and those of the xantphos-containing complexes are also compa-
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rable, with the more intense high-energy bands for [Cu(xantphos)(3)][PF6] being con-
sistent with the presence of the triazole unit. Each of the five complexes exhibits a low-
intensity, broad absorption with λmax in the range 381–384 nm which is assigned to metal-
to-ligand charge-transfer (MLCT). 
 
Figure 9. Solution absorption spectra (CH2Cl2, 2.5 × 10−5 mol dm−3) of the heteroleptic copper(I) 
complexes. 
Table 3. Absorption maxima for CH2Cl2 solutions of the copper(I) compounds (2.5 × 10−5 mol 
dm−3). 
Compound 
λmax/nm (εmax/dm3 mol−1 cm−1) 
π*π MLCT 
[Cu(POP)(1)][PF6] 
247 sh (28,500), 292 (23,400), 299 sh 
(22,300), 312 sh (14,800) 
381 (2900) 
[Cu(xantphos)(1)][PF6] 
247 sh (31,400), 285 (27,700), 315 sh 
(11,500) 
383 (2900)  
[Cu(POP)(2)][PF6] 
250 sh (25,600), 292 (21,900), 300 sh 
(20,500), 312 sh (14,800) 
384 (2850) 
[Cu(xantphos)(2)][PF6] 




247 (49,400), 282 (30,600), 312 sh 
(12,400)  
383 (3100) 
When de-aerated solutions of the compounds are excited into the MLCT band (λexc = 
365 nm), they emit very weakly in the orange region. All solution PLQYs were <1%. As 
has been described for related heteroleptic [Cu(P^P)(N^N)]+ complexes [18], the emissions 
are assigned to dπ(Cu)π*(bpy) (3MLCT) transitions. The emissions gain in intensity 
upon going from solution to powdered samples and we focus only on the solid-state data. 
The emission bands are unstructured (Figure 10) and values of λmaxem are given in Table 4. 
PLQY values range from 13% for [Cu(POP)(2)][PF6] to 28% for [Cu(xantphos)(1)][PF6]. As 
Table 4 shows, the xantphos-containing compounds have higher PLQY values than those in 
which P^P is POP. A biexponential fit was used for the lifetime decays (see Table 4), and 
values of τ were all of the same order of magnitude (5.1–8.7 μs). Pleasingly, the PLQYs for 
[Cu(xantphos)(1)][PF6], [Cu(xantphos)(2)][PF6] and [Cu(xantphos)(2)][PF6] are not signifi-
cantly lower than that of solid [Cu(xantphos)(6-Mebpy)][PF6] (33.8%), and the decay life-
times (Table 4) are similar to the 9.6 μs reported for [Cu(xantphos)(6-Mebpy)][PF6] [18], 
indicating that the switch from a 6-methyl to longer chain substituent is not detrimental 
to the photophysical properties. 
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Table 4. Emission properties of the [Cu(P^P)(N^N)][PF6] compounds in the solid state. 
Compound λexc /nm λmaxem/ nm PLQY/% τ/μs a τ(1)/μs (A1) τ(2)/μs (A2)
[Cu(POP)(1)][PF6] 365 552 17 5.4 5.94 (0.82) 2.30 (0.14) 
[Cu(xantphos)(1)][PF6] 365 542 28 7.2 8.29 (0.77) 2.16 (0.88) 
[Cu(POP)(2)][PF6] 365 555 13 5.1 5.47 (0.85) 1.88 (0.09) 
[Cu(xantphos)(2)][PF6] 365 546 26 8.7 9.64 (0.83) 2.26 (0.12) 
[Cu(xantphos)(3)][PF6] 365 548 25 7.1 8.64 (0.71) 2.24 (0.22) 
a A biexponential fit to the lifetime decay was used because a single exponential gave a poor fit; τ 
is calculated from τ = τ = /i i iA A   where Ai is the pre-exponential factor for the lifetime; 
values of τ(1), τ(2), A1 and A2 are given in the right-hand columns of the table. 
 
Figure 10. Normalized emission spectra of powdered samples of the heteroleptic copper(I) com-
plexes (λexc = 365 nm). 
3. Materials and Methods  
3.1. General 
1H-, 13C{1H}- and 31P{1H}-NMR spectra were recorded using a Bruker Avance III-500 
NMR spectrometer (Bruker BioSpin AG, Fällanden, Switzerland) at 298 K. 1H and 13C 
NMR chemical shifts were referenced to residual solvent peaks with respect to δ (TMS) = 
0 ppm and 31P NMR chemical shifts with respect to δ (85% aqueous H3PO4) = 0 ppm. Shi-
madzu LCMS-2020 (Shimadzu Schweiz GmbH, 4153 Reinach, Switzerland) and Bruker 
esquire 3000plus instruments (Bruker BioSpin AG) were used to record electrospray ion-
ization (ESI) mass spectra with samples introduced. Solution absorption and emission 
spectra were recorded using an Agilent 8453 spectrophotometer (Agilent Technologies 
Inc., Santa Clara, CA, USA) and Shimadzu RF-5301PC spectrofluorometer (Shimadzu 
Schweiz GmbH), respectively. PLQYs were measured using a Hamamatsu absolute pho-
toluminescence quantum yield spectrometer C11347 Quantaurus-QY, and emission life-
times and powder emission spectra were measured using a Compact Fluorescence life-
time Spectrometer C11367 Quantaurus-Tau (Hamamatsu, 4500 Solothurn, Switzerland) 
with an LED light source (exc = 365 nm). 
Cyclic voltammograms were recorded using a CH Instruments 900B potentiostat 
(CH Instruments, city, TX, USA) or a VersaSTAT 3F (AMETEK Princeton Applied Re-
search, Oak Ridge, TN, USA) respectively with [nBu4N][PF6] (0.1 mol dm–3) as the support-
ing electrolyte. The scan rate was 0.1 V s–1, and samples were dissolved in propylene car-
bonate (ca. 1 × 10−4 mol dm–3). The working electrode was glassy carbon (ALS Co. Ltd., 
131-0033 Tokyo, Japan), the reference electrode was a leakless Ag+/AgCl (eDAQ ET069-1) 
and the counter-electrode was a platinum wire (Advent Research Materials Ltd., OX29 
4JA Eynsham, UK). Final potentials were internally referenced with respect to the Fc/Fc+ 
couple. 
POP, Cu2O, 2-pyridylzinc bromide, nBuLi, iPr2NH and CuSO4.5H2O were purchased 
from Acros Organics (Chemie Brunschwig AG, Basel, Switzerland). HPF6, xantphos, 1-
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bromo-4-phenylbutane were purchased from Fluorochem (Chemie Brunschwig AG, Ba-
sel, Switzerland). (Ph3P)4Pd, phenylethyne and NaN3 were purchased from Sigma Aldrich 
(Sigma Aldrich Chemie GmbH, Steinheim, Germany). 
(2,2′-Bipyridin-6-yl)hexanoic acid (1) [20], 6-methyl-2,2′-bipyridine [24], 6-(2-bromo-
ethyl)-2,2′-bipyridine [25] and [Cu(NCMe)4][PF6] [26] were prepared according to litera-
ture procedures. 
3.2. Compound 2 
The reaction was carried out in flame-dried glassware on a Schlenk line under an N2 
atmosphere. Diisopropylamine (152 mg, 0.212 mL, 1.50 mmol, 1.0 eq.) was dissolved in 
dry THF (5 mL) and the mixture was cooled to −78 °C. n-Butyllithium in hexanes (408 mg, 
0.600 mL, 2.5 M, 1.50 mmol, 1.0 eq.) was added and the reaction mixture was stirred for 1 
h. A solution of 6-methyl-2,2′-bipyridine (93.2 mg, 0.25 mmol, 1.0 eq.) in dry THF (10 mL) 
was added and the mixture turned dark blue. After the reaction mixture was stirred for 
another 3 h, a solution of 1-bromo-4-phenylbutane in dry THF (10 mL) was added and the 
mixture was allowed to warm up to room temperature overnight keeping the vessel sub-
merged in the cooling bath. Then, saturated aqueous NH4Cl (15 mL) was added and the 
mixture was extracted with CH2Cl2 (3 × 35 mL). The combined organic fractions were 
dried over MgSO4 and filtered. After the solvent was removed under reduced pressure, 
the residue was purified by flash column chromatography using basic alumina to give 6-
(5-phenylpentyl)-2,2′-bipyridine (2) (138 mg, 0.46 mmol, 30%) as a colourless oil. For the 
chromatography, three columns were run: first column: cyclohexane/ethyl acetate, gradi-
ent from 3 to 20% ethyl acetate in cyclohexane over 16 column volumes, basic alumina; 
second column: cyclohexane/toluene (1:1), basic alumina; third column: cyclohexane/ethyl 
acetate (10:1), basic alumina. 1H-NMR (500 MHz, CDCl3) δ/ppm: 8.66 (m, 1H, HA6), 8.51 (d, 
J = 8.0 Hz, 1H, HA3), 8.29 (d, J = 7.9 Hz, 1H, HB3), 7.90 (dd, J = 9.4, 7.7 Hz, 1H, HA4), 7.80 (dd, 
J = 7.7, 7.7 Hz, 1H, HB4), 7.39 (m, 1H, HA5), 7.27 (m, 1H, HB5), 7.23 (m, 2H, HF3), 7.20 (m, 2H, 
HF2), 7.14 (m, 1H, HF4), 2.86 (t, J = 7.6, Hz, 2H, Ha), 2.62 (t, 7.6, Hz, 2H, He), 1.86 (m, 2H, Hb), 
1.70 (m, 2H, Hd), 1.45 (m, 2H, Hc). 13C{1H}-NMR (126 MHz, CDCl3) δ/ppm: 157.2 (CA2), 
156.2 (CB2), 150.0 (CA6), 143.5 (CE1), 138.0 (CB4), 137.6 (CA4), 129.2 (CE2), 129.1 (CE3), 126.5 
(CB6), 126.4 (CE4), 124.5 (CA5), 123.7 (CB5), 121.4 (CA3), 118.6 (CB3), 38.7 (Ca), 36.4 (Ce), 32.6 
(Cd), 30.2 (Cb), 29.6 (Cc). ESI MS: m/z 303.10 [M + H]+ (base peak, calc. 303.19), 325.11 [M + 
Na]+ (calc. 325.17). 
3.3. Compound 3 
6-(2-Bromoethyl)-2,2′-bipyridine (130 mg, 0.49 mmol, 1.0 eq.) was dissolved in DMF 
(2 mL), and NaN3 (48.2 mg, 0.74 mmol, 1.5 eq.) was added. The reaction mixture was 
stirred for ca. 15 h, and then water (5 mL) was added and the mixture was extracted with 
CH2Cl2 (4 × 15 mL). The solvent volume was reduced under vacuum. Phenylethyne (101 
mg, 0.99 mmol, 2.0 eq.), water (1 mL) and t-BuOH (5mL) were added, followed by 
CuSO4.5H2O (12.3 mg, 0.049 mmol, 0.1 eq.) and sodium ascorbate (97.9 mg, 0.49 mmol, 1.0 
eq.). The mixture was stirred at 35 °C for 72 h. The 1H NMR spectrum of the crude material 
indicated an incomplete conversion, and therefore more CuSO4.5H2O (123 mg, 0.49 mmol, 
1.0 eq.) and sodium ascorbate (97.9 mg, 0.49 mmol, 1.0 eq.) were added. The reaction mix-
ture was stirred at 35 °C for 5 h. Water (10 mL) was added and the mixture was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were washed with water (2 × 30 
mL) and dried over MgSO4. The solvent was removed under vacuum and the residue was 
dissolved in CH2Cl2 (10 mL). The organic layer was washed with a mixture (2 × 20 mL) of 
aqueous H2O2 (ca 1 %) and Na4EDTA (ca. 1% in 2 M aqueous NaOH). The organic layer 
was dried over MgSO4 and the solvent was removed under vacuum. The product was 
purified by column chromatography (Alox 90 basic, cyclohexane: ethyl acetate 2: 1) to give 
3 as a white solid (87.0 mg, 0.27 mmol, 54%). 1H-NMR (500 MHz, CDCl3) δ/ppm: 8.69 (d, J 
= 4.1 Hz, 1H, HA6), 8.41 (d, J = 7.9 Hz, 1H, HA3), 8.28 (d, J = 7.9 Hz, 1H, HB3), 7.79 (t, J = 7.7 
Hz, 1H, HA4), 7.74 (d, J = 7.9 Hz, 2H, HF2), 7.71 (t, J = 7.8 Hz, 1H, HB4), 7.62 (s, 1H, HE5), 7.37 
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(t, J = 7.6 Hz, 2H, HF3), 7.34−7.27 (overlapping m, 2H, HA5+F4), 7.09 (d, J = 7.6 Hz, 1H, HB5), 
4.98 (t, J = 6.9 Hz, 2H, Hb), 3.50 (t, J = 6.9 Hz, 2H, Ha). 13C{1H}-NMR (126 MHz, CDCl3) 
δ/ppm: 156.5 (CB6), 156.1 (CA2), 156.0 (CB2), 149.4 (CA6), 147.6 (CE4), 137.8 (CB4), 137.0 (CA4), 
130.8 (CF1), 128.9 (CF3), 128.1 (CF4), 125.8 (CF2), 124.0 (CA5), 123.8 (CB5), 121.2 (CA3), 120.2 (CE5), 
119.5 (CB3), 49.5 (Cb), 38.4 (Ca). ESI MS: m/z 328.08 [M + H]+ (base peak calc. 328.16), 350.08 
[M + Na]+ (calc. 350.14). 
3.4. [Cu(POP)(1)][PF6] 
[Cu(MeCN)4][PF6] (93.2 mg, 0.25 mmol, 1.0 eq.) and POP (148 mg, 0.28 mmol, 1.1 eq.) 
were dissolved in CH2Cl2 (30 mL) and the mixture stirred for 1 h. Compound 1 (67.6 mg, 
0.25 mmol, 1.0 eq.) was added and the mixture turned red, then orange while it was stirred 
for 1 h. The colour indicated the presence of homoleptic [Cu(1)2][PF6] and therefore addi-
tional POP (26.9 mg, 0.05 mmol, 0.2 eq.) was added. The mixture turned yellow and after 
stirring for 1.5 h, the mixture was filtered and the volume was reduced in vacuo. The 
product was precipitated by addition of Et2O and the solid was washed by sonication in 
Et2O (4 × 15 mL). After recrystallization, [Cu(POP)(1)][PF6] was isolated as a yellow solid 
(213 mg, 0.21 mmol, 84%). 1H-NMR (500 MHz, acetone-d6) δ/ppm: 10.45 (br s, 1H, HCOOH), 
8.71 (d, J = 5.0 Hz, 1H, HA6), 8.50 (d, J = 8.1 Hz, 1H, HA3), 8.43 (d, J = 7.9 Hz, 1H, HB3), 8.16 
(t, J = 7.9 Hz, 1H, HB4), 8.07 (td, J = 7.8, 1.6 Hz, 1H, HA4), 7.54 (d, J = 7.9 Hz, 1H, HB5), 7.46–
7.35 (overlapping m, 7H, HA5+C5+D4+D4′), 7.28 (t, J = 7.6 Hz, 8H, HD3+D3′), 7.21 (m, 2H, HC6), 
7.18–7.13 (overlapping m, 6H, HC4+D2′), 7.07 (m, 4H, HD2), 6.88 (dtd, J = 7.8, 4.0, 1.7 Hz, 2H, 
HC3), 2.81 (dd, J = 8.2, 8.2 Hz, 2H, Ha), 2.12 (t, J = 7.4 Hz, 2H, He), 1.31 (m, 2H, Hd), 1.25 (m, 
2H, Hb), 0.85 (m, 3H, Hc). 13C{1H}-NMR (126 MHz, acetone-d6) δ/ppm: 174.5 (CCOOH), 163.7 
(CB6), 158.8 (t, JPC = 6 Hz, CC1), 153.6 (t, JPC = 2 Hz, CA2), 152.4 (CB2), 150.3 (CA6), 140.1 (CB4), 
139.7 (CA4), 134.9 (CC3), 134.2 (t, JPC = 8 Hz, CD2′), 133.7 (t, JPC = 8 Hz, CD2), 133.2 (CC5), 132.1 
(t, JPC = 17 Hz, CD1), 131.1 (CD4′), 131.0 (CD4), 129.8 (t, JPC = 5 Hz, CD3+D3′), 126.7 (CA5), 126.1 (t, 
JPC = 2 Hz, CC2), 125.3 (CB5), 125.1 (t, JPC = 14 Hz, CC2), 123.6 (CA3), 121.4 (t, JPC = 2 Hz, CC6), 
121.2 (CB3), 40.8 (Ca), 34.0 (Ce), 29.5 (Cc), 28.7 (Cb), 25.5 (Cd). 31P{1H}-NMR (202 Hz, acetone-
d6) δ/ppm: −13.1, −144.3 (septet, JPF = 707 Hz, [PF6]−). ESI MS: m/z 871.21 [M−PF6]+ (base 
peak, calc. 871.23). UV-Vis (CH2Cl2, 2.5 × 10–5 mol dm–3): λ/nm (ε/dm3 mol–1 cm–1) 250 
(28,000), 292 (23,500), 380 (3000). Found: C 61.28, H 4.71, N 2.66; C52H46CuF6N2O3P3 re-
quires C 61.39, H 4.56, N 2.75%. 
3.5. [Cu(xantphos)(1)][PF6] 
[Cu(MeCN)4][PF6] (93.2 mg, 0.25 mmol, 1.0 eq.) was dissolved in CH2Cl2 (15 mL). A 
solution of xantphos (145 mg, 0.25 mmol, 1.0 eq.) and 1 (67.6 mg, 0.25 mmol, 1.0 eq.) in 
CH2Cl2 (30 mL) was added and the mixture turned red then yellow while being stirred for 
2 h at room temperature. The yellow solution was filtered and the solvent was removed 
from the filtrate in vacuo leaving a yellow solid that was washed with Et2O (4 × 10 mL), 
recrystallized and dried under vacuum. [Cu(xantphos)(1)][PF6] (259 mg, 0.25 mmol, 98%) 
was isolated as a yellow solid. 1H-NMR (500 MHz, acetone-d6) δ/ppm: 10.41 (s, 1H, HCOOH), 
8.62 (br, 1H, HA6), 8.50 (d, J = 8.2 Hz, 1H, HA3), 8.43 (d, J = 7.9 Hz, 1H, HB3), 8.20 (t, J = 7.9 
Hz, 1H, HB4), 8.10 (td, J = 7.8, 1.6 Hz, 1H, HA4), 7.87 (dd, J = 7.8, 1.5 Hz, 2H, HC5), 7.61 (d, J 
= 7.8 Hz, 1H, HB5), 7.53 (dd, J = 7.6, 5.1 Hz, 1H, HA5), 7.40 (t, J = 7.4 Hz, 2H, HD4′), 7.36–7.29 
(overlapping m, 4H, HC4+D4), 7.27 (m, 4H, HD3′), 7.20 (m, 4H, HD2′), 7.16 (m, 4H, HD3), 6.90 
(m, 4H, HD2), 6.71 (m, 2H, HC3), 2.48 (t, J = 7.6 Hz, 2H, Ha), 2.02 (t, J = 7.7 Hz, 2H, He), 1.95 
(s, 3H, Hxantphos-Me), 1.64 (s, 3H, Hxantphos-Me’), 1.23–1.12 (m, 4H, Hb+c), 0.51 (m, 2H, Hd). 13C{1H}- 
NMR (126 MHz, acetone-d6) δ/ppm: 174.3 (CCOOH), 163.0 (CB6), 155.9 (t, JPC = 6 Hz, CC1), 
153.5 (t, JPC = 2 Hz, CA2), 152.3 (t, JPC = 2 Hz, CB2), 150.0 (CA6), 140.3 (CB4), 139.9 (CA4), 135.1 
(t, JPC = 2 Hz, CC6), 134.0 (t, JPC = 8 Hz, CD2), 133.4 (t, JPC = 8 Hz, CD2′), 132.8 (m, CD1′), 132.3 
(m, CD1), 131.5 (CC3), 131.1 (CD4), 130.9 (CD4′), 129.9 (t, JPC = 5 Hz, CD3′), 129.7 (t, JPC = 5 Hz, 
CD3), 128.6 (CC5), 127.0 (CA5), 126.3 (t, JPC = 2 Hz, CC4), 125.5 (CB5), 123.8 (CA3), 121.50 (t, J = 
14 Hz, CC2), 121.46 (CB3), 41.2 (Ca), 37.0 (Cxantphos-bridge), 33.8 (br, Ce), 30.9 (br, Cxantphos-Me’), 28.8 
(Cd), 28.5 (Cb), 25.7 (br, Cxantphos-Me), 25.5 (Cc). 31P{1H}-NMR (202 Hz, acetone-d6) δ/ppm: 
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−13.1, −144.2 (septet, JPF = 708 Hz, [PF6]−). ESI MS: m/z 911.21 [M − PF6]+ (base peak, calc. 
911.26), 641.10 [Cu(xantphos)]+ (calc. 641.12). UV-Vis (CH2Cl2, 2.5 × 10–5 mol dm–3): λ/nm 
(ε/dm3 mol–1 cm–1) 248sh (31,500), 285 (28,000), 381 (3100). Satisfactory elemental analysis 
could not be obtained. 
3.6. [Cu(POP)(2)][PF6] 
[Cu(MeCN)4][PF6] (86.8 mg, 0.23 mmol, 1.0 eq.) and POP (126 mg, 0.23 mmol, 1.0 eq.) 
were dissolved in CH2Cl2 (30 mL) and the mixture was stirred for 2 h. Compound 2 (70.6 
mg, 0.23 mmol, 1.0 eq.) was added and the mixture turned red, then yellow while it was 
stirred for 2 h. The mixture was filtered and the volume was reduced under vacuum. The 
product was purified by preparative crystallization from CH2Cl2 by addition of Et2O. Af-
ter drying, [Cu(POP)(2)][PF6] was isolated as a yellow solid (191 mg, 0.18 mmol, 78%). 1H- 
NMR (500 MHz, acetone-d6) δ/ppm: 8.68 (d, J = 5.1 Hz, 1H, HA6), 8.50 (d, J = 8.1 Hz, 1H, 
HA3), 8.42 (d, J = 7.8 Hz, 1H, HB3), 8.15 (dd, J = 7.9, 7.9 Hz, 1H, HB4), 8.07 (dd, J = 7.9, 8.0 Hz, 
1H, HA4), 7.53 (d, J = 7.8 Hz, 1H, HB5), 7.45–7.35 (overlapping m, 7H, HD4+D4′+C5+A5), 7.26 (m, 
10H, HD3+D3′+E3), 7.19–7.12 (overlapping m, 11H, HE2+E4+C4+C6+D2′), 7.05 (m, 4H, HD2), 6.88 (m, 
1H, HC3), 2.80 (m, 2H, Ha), 2.44 (m, 2H, He), 1.28 (m, 2H, Hd), 1.27 (m, 2H, Hb), 0.85 (m, 2H, 
Hc). 13C{1H}-NMR (126 MHz, acetone-d6) δ/ppm: 163.8 (CB6), 158.8 (t, JPC = 6 Hz, CC1), 153.6 
(CA2), 152.4 (CB2), 150.2 (CA6), 143.3 (CE1), 140.1 (CB4), 139.7 (CA4), 135.0 (CC3), 134.2 (t, JPC = 8 
Hz, CD2′), 133.7 (t, JPC = 8 Hz, CD2), 133.2 (CC5), 132.1 (m, CD1+D1′), 131.0 (CD4+D4′), 129.8 (t, JPC 
= 5 Hz, CD3+D3′), 129.3 (CE2/E3), 129.1 (CE2/E3), 126.6 (CA5), 126.5 (CE4), 126.1 (t, JPC = 2 Hz, CC4), 
125.4 (CB5), 125.0 (t, JPC = 14 Hz, CC2), 123.6 (CA3), 121.3 (t, JPC = 2 Hz, CC6), 121.2 (CB3), 40.9 
(Ca), 36.3 (Ce), 32.1 (Cd), 29.5 (Cc), 29.0 (Cb). 31P{1H}-NMR (202 MHz, 298 K, acetone-d6) 
δ/ppm: −13.1, −144.2 (septet, JPF = 707 Hz, [PF6]–). ESI-MS m/z: 903.25 [M − PF6]+ (base peak, 
calc. 903.27), 601.09 [Cu(POP)]+ (calc. 601.09). UV-Vis (CH2Cl2, 2.5 × 10–5 mol dm–3): λ/nm 
(ε/dm3 mol–1 cm–1) 250 (25,750), 290 (22,000), 383 (3000). Found: C 64.44, H 4.91, N 2.67; 
C57H50CuF6N2OP3 requires C 65.23, H 4.80, N 2.67. 
3.7. [Cu(xantphos)(2)][PF6] 
[Cu(MeCN)4][PF6] (86.1 mg, 0.23 mmol, 1.0 eq.), xantphos (134 mg, 0.23 mmol, 1.0 
eq.) and 2 (70.0 mg, 0.23 mmol, 1.0 eq.) were dissolved in CH2Cl2 (30 mL). The mixture 
turned red, then yellow while it was stirred for 2 h. The mixture was filtered and the vol-
ume was reduced under vacuum. The product was purified by preparative crystallization 
from CH2Cl2 by addition of Et2O. AFter drying, [Cu(xantphos)(2)][PF6] was isolated as a 
yellow solid (204 mg, 0.19 mmol, 81%). 1H-NMR (500 MHz, acetone-d6) δ/ppm: 8.59 (m, 
1H, HA6), 8.51 (d, J = 8.2 Hz, 1H, HA3), 8.43 (d, J = 7.9 Hz, 1H, HB3), 8.19 (dd, J = 7.9, 7.9 Hz, 
1H, HB4), 8.10 (dd, J = 9.1, 7.7 Hz, 1H, HA4), 7.84 (dd, J = 7.9, 1.4 Hz, 2H, HC5), 7.58 (d, J = 7.7 
Hz, 1H, HB5), 7.52 (dd, J = 6.8, 5.5 Hz, 1H, HA5), 7.39 (t, J = 7.4 Hz, 2H, HD4′), 7.34 (t, J = 7.5 
Hz, 2H, HD4), 7.26 (m, 2H, HC4), 7.25 (m, 4H, HD3′), 7.23 (m, 2H, HE3), 7.19 (m, 4H, HD2′), 7.15 
(m, 4H, HD3), 7.15 (m, 1H, HE4), 7.05 (m, 2H, HE2), 6.91 (m, 4H, HD2), 6.7 (m, 1H, HC3), 2.49 
(dd, J = 7.6 Hz, 2H, Ha), 2.34 (dd, J = 7.6 Hz, 2H, He), 1.93 (s, 3H, Hxantphos-Me’), 1.65 (s, 3H, 
Hxantphos-Me), 1.22 (m, 2H, Hd), 1.19 (m, 2H, Hb), 0.55 (m, 2H, Hc). 13C{1H}-NMR (126 MHz, 
acetone-d6) δ/ppm: 153.5 (CA2), 163.1 (CB6), 155.8 (t, JPC = 6 Hz, CC1), 152.3 (CB2), 150.0 (CA6), 
143.2 (CE1), 140.3 (CB4), 139.9 (CA4), 135.1 (t, JPC = 2 Hz, CC6), 134.0 (t, JPC = 8 Hz, CD2), 133.4 
(t, JPC = 8 Hz, CD2′), 132.8 (t, JPC = 16 Hz, CD1′), 132.4 (t, JPC = 18 Hz, CD1), 131.5 (CC3), 131.1 
(CD4), 130.9 (CD4′), 129.9 (t, JPC = 5 Hz, CD3′), 129.7 (t, JPC = 5 Hz, CD3), 129.7 (CE3), 129.1 (CE2), 
128.6 (CC5), 127.0 (CA5), 126.5 (CE4), 126.3 (t, J = 2 Hz, CC4), 125.5 (CB5), 123.8 (CA3), 121.5 (t, 
JPC = 13 Hz, CC2), 121.4 (CB3), 41.3 (Ca), 36.9 (Cxantphos-bridge), 36.1 (Ce), 32.2 (Cd), 30.8 (Cxantphos-
Me), 28.9 (Cc), 28.7 (Cb), 25.9 (Cxantphos-Me’). 31P{1H}-NMR (202 MHz, 298 K, acetone-d6) δ/ppm: 
−13.1, −144.2 (septet, JPF = 707 Hz). ESI-MS m/z: 943.32 [M − PF6]+ (base peak, calc. 943.30), 
641.11 [Cu(xantphos)]+ (calc. 641.12). UV-Vis (CH2Cl2, 2.5 × 10–5 mol dm–3): λ/nm (ε/dm3 
mol–1 cm–1) 248 (26,500), 284 (25,000), 383 (2750). Found: C 65.50, H 4.92, N 2.57; 
C60H54CuF6N2OP3 requires C 66.14, H 5.00, N 2.57. 




[Cu(MeCN)4][PF6] (42.1 mg, 0.11 mmol, 1.0 eq.) was dissolved in CH2Cl2 (15 mL). A 
solution of xantphos (65.4 mg, 0.11 mmol, 1.0 eq.) and 3 (37.0 mg, 0.11 mmol, 1.0 eq.) was 
added and the mixture turned red then yellow as it was stirred for 2 h at room tempera-
ture. The reaction mixture was filtered and the solvent was removed from the filtrate to 
yield a yellow solid that was washed with Et2O (4 × 10 mL), recrystallized and dried under 
vacuum. [Cu(xantphos)(3)][PF6] was isolated as a yellow solid (125 mg, 0.11 mmol, 99%). 
1H-NMR (500 MHz, acetone-d6) δ/ppm: 8.56 (d, J = 8.2 Hz, 1H, HA3), 8.49 (d, J = 7.9 Hz, 1H, 
HB3), 8.32 (br s, 1H, HA6), 8.14 (t, J = 7.9 Hz, 1H, HB4), 8.11 (t, J = 7.9 Hz, 1H, HA4), 7.87 (d, J 
= 7.8 Hz, 2H, HC5), 7.73 (d, J = 7.7 Hz, 2H, HF2), 7.68 (s, 1H, HE5), 7.45 (dd, J = 7.6, 5.3 Hz, 
1H, HA5), 7.43–7.36 (overlapping m, 5H, HB5+D4+F3), 7.34−7.27 (overlapping m, 5H, HF4+C4+D4′), 
7.25 (m, 4H, HD3′), 7.18−7.09 (overlapping m, 8H, HD2′+D3), 6.97 (m, 4H, HD2), 6.70 (m, 2H, 
HC3), 4.20 (t, J = 6.9 Hz, 2H, Hb), 3.31 (br t, 3H, Ha), 1.87 (s, 3H, Hxantphos-Me), 1.75 (s, 3H, 
Hxantphos-Me’). 13C{1H}-NMR (126 MHz, acetone-d6) δ/ppm: 158.6 (CB6), 155.7 (t, JPC = 6.3 Hz, 
CC1), 153.3 (CA2), 153.0 (CB2), 149.8 (CA6), 147.9 (CE4), 140.5 (CB4), 140.0 (CA4), 135.1 (t, JPC = 2 
Hz, CC6), 133.9 (t, JPC = 8 Hz, CD2), 133.5 (t, JPC = 8 Hz, CD2′), 132.5 (t, JPC = 17 Hz, CD1′), 132.0 
(t, JPC = 18 Hz, CD1), 131.9 (CF1), 131.7 (CC3), 131.11 (CD4′), 131.06 (CD4), 129.92 (t, JPC = 5 Hz, 
CD3′), 129.88 (t, JPC = 5 Hz, CD3), 129.7 (CF3), 128.9 (CF4), 128.8 (CC5), 127.1 (CA5), 126.5 (t, JPC = 
2 Hz, CC4), 126.3 (CF2), 126.0 (CB5), 124.1 (CA3), 122.4 (CB3), 121.23 (t, JPC = 14 Hz, CC2), 121.17 
(CE5), 48.1 (Cb), 40.9 (Ca), 37.0 (Cxantphos-bridge), 29.6 (Cxantphos-Me’), 27.2 (Cxantphos-Me). 31P{1H}-NMR 
(202 Hz, acetone-d6) δ/ppm: −12.7, −144.3 (septet, JPF = 707 Hz). ESI MS: m/z 968.26 [M − 
PF6]+ (calc. 968.27), 811.16 [Cu(xantphos)(Mebpy)]+ (base peak calc. 811.21), 641.09 
[Cu(xantphos)]+ (calc. 641.12). UV-Vis (CH2Cl2, 2.5 × 10–5 mol dm–3): λ/nm (ε/dm3 mol–1 cm–
1) 248 (50,000), 283 (30,000), 385 (3000). Found: C 63.24, H 4.63, N 6.19; C59H49CuF6N5OP3 
requires C 63.58, H 4.43, N 6.28%. 
3.9. Crystallography 
Single crystal data were collected on a Bruker APEX-II diffractometer with data re-
duction, solution and refinement using the programs APEX [27] and CRYSTALS [28]. The 
program CSD Mercury 2020.1 [29] was used for the structure analysis and structural fig-
ures. SQUEEZE [30] was used to treat the solvent region, and the electron density re-
moved equated to half a molecule of Et2O per complex cation. The anion in 
[Cu(xantphos)(3)][PF6].0.5Et2O was orientationally disordered and was modelled over 
two positions with fractional occupancies of 0.70 and 0.30. The phenyl ring in ligand 3 was 
also orientationally disordered over two positions, and the rings had to be refined isotrop-
ically and with rigid body restraints. 
C61H54CuF6N5O1.5P3, Mr = 1151.59, yellow block, triclinic, space group P–1, a = 
10.9834(7), b = 15.5458(9), c = 18.6079(11) Å, α = 110.395(2), β = 94.433(2),  = 110.363(2)o, V 
= 2719.7(3) Å3, Dc = 1.41 g cm–3, T = 123 K, Z = 2, (CuKα) = 1.981 mm–1. Total 36,022 reflec-
tions, 10,070 unique (Rint = 0.029). Refinement of 9303 reflections (682 parameters) with I > 
2(I) converged at final R1 = 0.0628 (R1 all data = 0.0660), wR2 = 0.1619 (wR2 all data = 
0.1626), gof = 1.0476. CCDC 2047805. 
4. Conclusions 
We have prepared and characterized two new bpy ligands, 2 and 3, which contain 
extended 6-substituents. These and ligand 1 have been incorporated into heteroleptic cop-
per(I) coordination compounds [Cu(POP)(1)][PF6], [Cu(xantphos)(1)][PF6], [Cu(POP)(2)] 
[PF6], [Cu(xantphos)(2)][PF6], and [Cu(xantphos)(3)][PF6]. Characterization of these com-
pounds included the determination of the single-crystal structure of 
[Cu(xantphos)(3)][PF6].0.5Et2O, and this confirmed the expected distorted tetrahedral cop-
per(I) coordination environment. The 6-substituent is oriented so that the α- and β-CH2 
units reside in the xanthene ‘bowl’ of the xantphos ligand, and the conformation of the 
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chain is such that is desymmetrizes the structure. This has implications for the interpreta-
tion of the solution NMR spectra of the five complexes, and analysis of the 2D spectra 
provides evidence for different combinations of possible dynamic processes operating in 
different compounds. Each copper(I) complex exhibits a broad MLCT absorption band 
with λmax in the range 381–384 nm, and excitation into this band results in a very weak, 
orange emission in solution. In the solid state, the heteroleptic complexes exhibit emission 
maxima between 542 nm and 555 nm, and PLQY values range from 13% for 
[Cu(POP)(2)][PF6] to 28% for [Cu(xantphos)(1)][PF6]. These quantum yields are not signif-
icantly lower than that of [Cu(xantphos)(6-Mebpy)][PF6] and the decay lifetimes of the 
new compounds are also similar to that of the analogous 6-Mebpy containing derivative. 
These results demonstrate that going from a 6-methyl to longer-chain substituent is not 
unfavourable in terms of the photophysical properties. 
Supplementary Materials: The following are available online, Figures S1–S4: NMR spectra of lig-
ands 2 and 3; Figures S5 and S6: Structural figures of the [Cu(xantphos)(3)]+ cation; Figures S7–S23: 
NMR spectra of the heteroleptic complexes; Figure S24: Cyclic voltammograms of [Cu(POP)(2)][PF6] 
and [Cu(xantphos)(2)][PF6]. 
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